Overview

The DEPOT Study (Dry Eye Prescription Options for Therapy)

Status:
Recruiting
Trial end date:
2022-08-26
Target enrollment:
Participant gender:
Summary
Assessing DEXTENZA efficacy and safety when placed within the lower eyelid canaliculus for dry eye flares in comparison to topical loteprednol suspension.
Phase:
Phase 4
Details
Lead Sponsor:
Research Insight LLC
Treatments:
Dexamethasone